Andrea Matucci

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (7)

Apostolos Bossios

Karolinska University Hospital

SWEDEN

View details

Petr Panzner

Charles University, Faculty of Medicine in Pilsen

CZECH REPUBLIC

View details

Giandomenico Maggiore

ITALY

View details

Alessandra Vultaggio

section of biochemistry university of florence italy

ITALY

View details

fabiano di marco

University of Milan

ITALY

View details

Patrizio Pasqualetti

Associate Professor of Medical Statistics

Sapienza University of Rome

ITALY

View details

Oreste Gallo

Head, Full Professor

University of Florence

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrea Matucci

Research Interests

Explore related searches

Contact this professor

Articles (11)

Alert Card for Patients on Biologicals and Immunosuppressives: An EAACI Position Paper

Benralizumab: from tissue distribution to eosinophilic cytotoxicity up to potential immunoregulation

Sustained Efficacy and Low Rate of Adverse Events of Dupilumab in Type-2 CRSwNP Over 48 Months

Asthma remission one, none and one-hundred thousand: the relevance of the patient’s view

Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report

Benralizumab: The Immuno-Pharmacological State of the Art

Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report

Effects of Mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical study

Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature

Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature

Blood <scp>CD62L<sup>low</sup></scp> inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab

Collaborators (7)

Apostolos Bossios

Petr Panzner

Giandomenico Maggiore

Alessandra Vultaggio

fabiano di marco

Patrizio Pasqualetti

Oreste Gallo

Make your next move.